We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cougar Biotechnology (MM) | NASDAQ:CGRB | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 42.96 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
Johnson & Johnson (JNJ) said Thursday it has struck a deal to buy Cougar Biotechnology Inc. (CGRB), a development-stage biopharmaceutical company with a specific focus on cancer treatment, for approximately $1 billion in a cash tender offer.
The deal involves a tender for all Cougar shares at $43 apiece, a premium over the company's Thursday close of $36.98, although Cougar stock rose to $42.10 in after-hours trading.
-By Michael Kitchen; 415-439-6400; AskNewswires@dowjones.com
1 Year Cougar Biotechnology (MM) Chart |
1 Month Cougar Biotechnology (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
